Ex vivo corneal epithelial wound healing following exposure to ophthalmic nonsteroidal anti-inflammatory drugs.

about

The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.

P2860

Q36240200-776F2DBA-5AFD-476D-B825-BAD8749C955A

P2860

Ex vivo corneal epithelial wound healing following exposure to ophthalmic nonsteroidal anti-inflammatory drugs.

Item

http://www.wikidata.org/entity/Q42704847

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Ex vivo corneal epithelial wou ...... oidal anti-inflammatory drugs.

@en

Ex vivo corneal epithelial wou ...... oidal anti-inflammatory drugs.

@nl

type

Item

label

Ex vivo corneal epithelial wou ...... oidal anti-inflammatory drugs.

@en

Ex vivo corneal epithelial wou ...... oidal anti-inflammatory drugs.

@nl

prefLabel

Ex vivo corneal epithelial wou ...... oidal anti-inflammatory drugs.

@en

Ex vivo corneal epithelial wou ...... oidal anti-inflammatory drugs.

@nl

P1476

Ex vivo corneal epithelial wou ...... oidal anti-inflammatory drugs.

@en

P2093

David A Hollander

http://www.w3.org/2001/XMLSchema#string

Keping Xu

http://www.w3.org/2001/XMLSchema#string

Linda Villanueva

http://www.w3.org/2001/XMLSchema#string

Mark McDermott

http://www.w3.org/2001/XMLSchema#string

Rhett M Schiffman

http://www.w3.org/2001/XMLSchema#string

P2860

Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs.

Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.

Double-masked study of the effects of nepafenac 0.1% and ketorolac 0.4% on corneal epithelial wound healing and pain after photorefractive keratectomy.

Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK).

Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells.

Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic.

Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care.

Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells.

High glucose suppresses epidermal growth factor receptor/phosphatidylinositol 3-kinase/Akt signaling pathway and attenuates corneal epithelial wound healing.

Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension

P304

269-274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OPTH.S16778

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51020868

http://www.w3.org/2001/XMLSchema#string

P698

21468332

http://www.w3.org/2001/XMLSchema#string

P932

3065566

http://www.w3.org/2001/XMLSchema#string

Ex vivo corneal epithelial wound healing following exposure to ophthalmic nonsteroidal anti-inflammatory drugs.

about

P2860

P2860

Ex vivo corneal epithelial wound healing following exposure to ophthalmic nonsteroidal anti-inflammatory drugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932